A. Mieke Timmermans

877 citations

15 papers · 629 indexed · h-index 11

Co-authors: John W.M. Martens John A. Foekens Stefan Sleijfer Marcel Smid Reno Debets Maxime P. Look Dora Hammerl Arzu Umar
Topics: Cancer Cells and Metastasis (5 papers)Cancer Genomics and Diagnostics (4 papers)CAR-T cell therapy research (2 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Journal of Clinical Investigation Cancer Research Scientific Reports
Partner nations: Netherlands Denmark United States

In The Last Decade

A. Mieke Timmermans

13 papers receiving 613 citations

Peers

Countries citing papers authored by A. Mieke Timmermans

Since Specialization

Citations

This map shows the geographic impact of A. Mieke Timmermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mieke Timmermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mieke Timmermans more than expected).

Fields of papers citing papers by A. Mieke Timmermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mieke Timmermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mieke Timmermans. The network helps show where A. Mieke Timmermans may publish in the future.

Co-authorship network of co-authors of A. Mieke Timmermans

This figure shows the co-authorship network connecting the top 25 collaborators of A. Mieke Timmermans. A scholar is included among the top collaborators of A. Mieke Timmermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Mieke Timmermans. A. Mieke Timmermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive disease 2025 ·Breast Cancer Research ·(unknown),A. Mieke Timmermans,Michael A. Carpenter,Marcel Smid,Michael A. den Bakker,Carolien H. M. van Deurzen,Reuben S. Harris,John W.M. Martens	0
2	CD3xHER2 bsAb‐Mediated Activation of Resting T‐cells at HER2 Positive Tumor Clusters Is Sufficient to Trigger Bystander Eradication of Distant HER2 Negative Clusters Through IFNγ and TNFα 2025 ·European Journal of Immunology ·(unknown),Patrick Engelberts,(unknown),A. Mieke Timmermans,(unknown),Elsa Neubert,Erik H.J. Danen	0
3	Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation 2023 ·Cancers ·(unknown),A. Mieke Timmermans,Bernadette A. M. Heemskerk‐Gerritsen,Anita Trapman-Jansen,(unknown),Wendy J. C. Prager‐van der Smissen,(unknown),(unknown),(unknown),Pieter J. Westenend,Carolien H. M. van Deurzen,John W.M. Martens,Maartje J. Hooning,Antoinette Hollestelle	3
4	HER2-low breast cancer shows a lower immune response compared to HER2-negative cases 2022 ·Scientific Reports ·(unknown),Marcel Smid,A. Mieke Timmermans,(unknown),(unknown),Renée Foekens,Anita M.A.C. Trapman,B.A.M. Heemskerk-Gerritsen,Agnes Jager,John W.M. Martens,Carolien H. M. van Deurzen	30
5	Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer 2020 ·Scientific Reports ·Anna E.M. Bastiaansen,A. Mieke Timmermans,Marcel Smid,Carolien H. M. van Deurzen,Esther Hulsenboom,Wendy J. C. Prager‐van der Smissen,Renée Foekens,Anita Trapman-Jansen,Peter A.E. Sillevis Smitt,Theo M. Luider,John W.M. Martens,Martijn M. VanDuijn	12
6	Breast cancer genomics and immuno-oncological markers to guide immune therapies 2017 ·Seminars in Cancer Biology ·Dora Hammerl,Marcel Smid,A. Mieke Timmermans,Stefan Sleijfer,John W.M. Martens,Reno Debets	115
7	Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients 2016 ·Scientific Reports ·Ning Qing Liu,Tommaso De Marchi,A. Mieke Timmermans,Anita Trapman-Jansen,Renée Foekens,Maxime P. Look,Marcel Smid,Carolien H. M. van Deurzen,Paul N. Span,Fred C.G.J. Sweep,(unknown),Vera Timmermans‐Wielenga,John A. Foekens,John W.M. Martens,Arzu Umar	16
8	Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant 2015 ·Journal of Clinical Investigation ·Wies van Roosmalen,Sylvia E. Le Dévédec,Ofra Golani,Marcel Smid,Irina Pulyakhina,A. Mieke Timmermans,Maxime P. Look,(unknown),Chantal Pont,Marjo de Graauw,(unknown),(unknown),Gabriella Rustici,Peter A.C. ’t Hoen,John W.M. Martens,John A. Foekens,Benjamin Geiger,Bob van de Water	98
9	High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer 2014 ·Annals of Oncology ·(unknown),A. Mieke Timmermans,Maxime P. Look,Marion E. Meijer‐van Gelder,(unknown),Carolien H. M. van Deurzen,John W.M. Martens,Stefan Sleijfer,John A. Foekens,P.M.J.J. Berns,Maurice P.H.M. Jansen	46
10	Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response 2014 ·Molecular & Cellular Proteomics ·Ning Qing Liu,Tommaso De Marchi,A. Mieke Timmermans,Robin Beekhof,Anita Trapman-Jansen,Renée Foekens,Maxime P. Look,Carolien H. M. van Deurzen,Paul N. Span,Fred C.G.J. Sweep,(unknown),Vera Timmermans‐Wielenga,Reno Debets,John W.M. Martens,John A. Foekens,Arzu Umar	47
11	Abstract 806: Extracellular matrix metalloprotease inducer (EMMPRIN) and CD44 protein complexes are exclusively formed in basal- and normal-like breast cancer cell lines 2012 ·Cancer Research ·A. Mieke Timmermans,Hamed Montazeri,Anita Trapman-Jansen,John W.M. Martens,John A. Foekens,Arzu Umar	1
12	CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes 2011 ·Cancer Letters ·Bianca Mostert,Jaco Kraan,Anieta M. Sieuwerts,Petra van der Spoel,Joan Bolt‐de Vries,Wendy J. C. Prager‐van der Smissen,Marcel Smid,A. Mieke Timmermans,John W.M. Martens,Jan W. Gratama,John A. Foekens,Stefan Sleijfer	41
13	Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 2010 ·Breast Cancer Research and Treatment ·Bianca Mostert,Jaco Kraan,Joan Bolt‐de Vries,Petra van der Spoel,Anieta M. Sieuwerts,Mieke Schutte,A. Mieke Timmermans,Renée Foekens,John W.M. Martens,Jan‐Willem Gratama,John A. Foekens,Stefan Sleijfer	98
14	Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer 2009 ·Molecular & Cellular Proteomics ·Arzu Umar,Hyuk Kang,A. Mieke Timmermans,Maxime P. Look,Marion E. Meijer‐van Gelder,Michael A. den Bakker,Navdeep Jaitly,John W.M. Martens,Theo M. Luider,John A. Foekens,Ljiljana Paša‐Tolić	85
15	Method optimisation for peptide profiling of microdissected breast carcinoma tissue by matrix‐assisted laser desorption/ionisation‐time of flight and matrix‐assisted laser desorption/ionisation‐time of flight/time of flight‐mass spectrometry 2005 ·PROTEOMICS ·Arzu Umar,(unknown),A. Mieke Timmermans,John A. Foekens,Theo M. Luider	37

About A. Mieke Timmermans

A. Mieke Timmermans is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 15 papers that have together received 629 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (4 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (241 citations), Oncology (285 citations) and Molecular Biology (335 citations). A. Mieke Timmermans has collaborated with scholars based in Netherlands, Denmark and United States. Frequent co-authors include John W.M. Martens, John A. Foekens, Stefan Sleijfer, Marcel Smid, Reno Debets, Maxime P. Look, Dora Hammerl, Arzu Umar, Theo M. Luider and Renée Foekens. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact